Why the study?
Does ticagrelor improve twelve-month clinical outcomes compared to prasugrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention?
Does ticagrelor improve twelve-month clinical outcomes compared to prasugrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
NCT01944800, Prospective, Randomized Trial of Ticagrelor Vs. Prasugrel in Patients With Acute Coronary Syndrome-Full-Text View-ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT01944800.
No takes yet. Share an insight, caveat, or question.
Coughlan et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: